Paramagnetic hollow silica nanospheres for in vivo targeted ultrasound and magnetic resonance imaging

Biomaterials

Volumn 35, Issue 20, 2014, Pages 5381-5392

  An, Lu ^a   Hu, He ^a   Du, Jing ^b   Wei, Jie ^a   Wang, Li ^a   Yang, Hong ^a   Wu, Dongmei ^c   Shi, Haili ^a   Li, Fenghua ^b   Yang, Shiping ^a  

^a SHANGHAI NORMAL UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c EAST CHINA NORMAL UNIVERSITY   (China)

Author keywords

Biodistribution; Hollow silica nanospheres; Magnetic resonance imaging; Toxicity; Ultrasound imaging

Indexed keywords

AMINO ACIDS; GADOLINIUM COMPOUNDS; MAMMALS; NANOSPHERES; PARAMAGNETISM; RESONANCE; SILICA; TOXICITY; TUMORS; ULTRASONIC IMAGING;

ARGININE-GLYCINE-ASPARTIC ACIDS; BIOCHEMICAL ANALYSIS; BIODISTRIBUTIONS; EFFICIENCY ASSESSMENT; HEMOLYTIC ACTIVITY; HOLLOW SILICA NANOSPHERES; INTRAVENOUS ADMINISTRATION; ULTRASOUND IMAGING;

MAGNETIC RESONANCE IMAGING;

CONTRAST MEDIUM; NANOSPHERE; PENTETIC ACID; SILICON DIOXIDE; ARGINYL-GLYCYL-ASPARTIC ACID; GADOLINIUM PENTETATE; OLIGOPEPTIDE; POLYSTYRENE DERIVATIVE;

ANIMAL CELL; ARTICLE; BLOOD ANALYSIS; BODY WEIGHT; CANCER TISSUE; CONJUGATION; CONTROLLED STUDY; CYTOTOXICITY; ECHOGRAPHY; HISTOLOGY; IN VITRO STUDY; IN VIVO STUDY; LIVER; LUNG PARENCHYMA; MALE; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PARTICLE SIZE; PRIORITY JOURNAL; QUANTITATIVE STUDY; ANIMAL; CANCER TRANSPLANTATION; CHEMISTRY; DISEASE MODEL; DRUG DELIVERY SYSTEM; FECES; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LUNG; METABOLISM; NEOPLASM; NUDE MOUSE; PROCEDURES; TISSUE DISTRIBUTION; TUMOR CELL LINE;

MUS;

ADMINISTRATION, INTRAVENOUS; ANIMALS; CELL LINE, TUMOR; CONTRAST MEDIA; DISEASE MODELS, ANIMAL; DRUG DELIVERY SYSTEMS; FECES; GADOLINIUM DTPA; HUMANS; LIVER; LUNG; MAGNETIC RESONANCE IMAGING; MALE; MICE; MICE, NUDE; NANOSPHERES; NEOPLASM TRANSPLANTATION; NEOPLASMS; OLIGOPEPTIDES; POLYSTYRENES; SILICON DIOXIDE; TISSUE DISTRIBUTION;

EID: 84899473765     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2014.03.030     Document Type: Article

References (58)

1. 188Re-labeled micelles containing a cyanine-type photosensitizer. ACS Nano 2011, 5:5594-5607.
2. Lee J.E., Lee N., Kim H., Kim J., Choi S.H., Kim J.H., et al. Uniform mesoporous dye-doped silica nanoparticles decorated with multiple magnetite nanocrystals for simultaneous enhanced magnetic resonance imaging, fluorescence imaging, and drug delivery. J Am Chem Soc 2009, 132:552-557.
3. Toy R., Hayden E., Camann A., Berman Z., Vicente P., Tran E., et al. Multimodal in vivo imaging exposes the voyage of nanoparticles in tumor microcirculation. ACS Nano 2013, 7:3118-3129.
4. Liu Z., Pu F., Liu J., Jiang L., Yuan Q., Li Z., et al. PEGylated hybrid ytterbia nanoparticles as high-performance diagnostic probes for in vivo magnetic resonance and X-ray computed tomography imaging with low systemic toxicity. Nanoscale 2013, 5:4252-4261.
5. Lee J.H., Huh Y.M., Jun Y.W., Seo J.W., Jang J.T., Song H.T., et al. Artificially engineered magnetic nanoparticles for ultra-sensitive molecular imaging. Nat Med 2007, 13:95-99.
6. 1 MRI-SPECT) imaging. ACS Nano 2012, 7:500-512.
7. Weber W.A., Grosu A.L., Czernin J. Technology insight: advances in molecular imaging and an appraisal of PET/CT scanning. Nat Clin Prac Oncol 2008, 5:160-170.
8. Lee J.H., Jun Y.W., Yeon S.I., Shin J.S., Cheon J. Dual-mode nanoparticle probes for high-performance magnetic resonance and fluorescence imaging of neuroblastoma. Angew Chem Int Ed 2006, 45:8160-8162.
9. Wang S., Jarrett B.R., Kauzlarich S.M., Louie A.Y. Core/shell quantum dots with high relaxivity and photoluminescence for multimodality imaging. J Am Chem Soc 2007, 129:3848-3856.
10. Kim H.M., Lee H., Hong K.S., Cho M.Y., Sung M.H., Poo H., et al. Synthesis and high performance of magnetofluorescent polyelectrolyte nanocomposites as MR/near-infrared multimodal cellular imaging nanoprobes. ACS Nano 2011, 5:8230-8240.
11. Yang H., Zhuang Y., Hu H., Du X., Zhang C., Shi X., et al. Silica-coated manganese oxide nanoparticles as a platform for targeted magnetic resonance and fluorescence imaging of cancer cells. Adv Funct Mater 2010, 20:1733-1741.
12. Lindner J.R. Microbubbles in medical imaging: current applications and future directions. Nat Rev Drug Discov 2004, 3:527-533.
13. Kang E., Min H.S., Lee J., Han M.H., Ahn H.J., Yoon I.C., et al. Nanobubbles from gas-generating polymeric nanoparticles: ultrasound imaging of living subjects. Angew Chem Int Ed 2010, 49:524-528.
14. 2 dual-modal contrast agent. Adv Mater 2012, 24:6223-6228.
15. Aime S., Fasano M., Terreno E. Lanthanide(III) chelates for NMR biomedical applications. Chem Soc Rev 1998, 27:19-29.
16. Manus L.M., Mastarone D.J., Waters E.A., Zhang X.Q., Schultz-Sikma E.A., MacRenaris K.W., et al. Gd(III)-nanodiamond conjugates for MRI contrast enhancement. Nano Lett 2009, 10:484-489.
17. Malvindi M.A., Greco A., Conversano F., Figuerola A., Corti M., Bonora M., et al. Magnetic/silica nanocomposites as dual-mode contrast agents for combined magnetic resonance imaging and ultrasonography. Adv Funct Mater 2011, 21:2548-2555.
18. Hong G., Lee J.C., Robinson J.T., Raaz U., Xie L., Huang N.F., et al. Multifunctional in vivo vascular imaging using near-infrared II fluorescence. Nat Med 2012, 18:1841-1846.
19. Xie J., Liu G., Eden H.S., Ai H., Chen X. Surface-engineered magnetic nanoparticle platforms for cancer imaging and therapy. Acc Chem Res 2011, 44:883-892.
20. Lin P.L., Eckersley R.J., Hall E.A.H. Ultrabubble: a laminated ultrasound contrast agent with narrow size range. Adv Mater 2009, 21:3949-3952.
21. Liu H.L., Hua M.Y., Yang H.W., Huang C.Y., Chu P.C., Wu J.S., et al. Magnetic resonance monitoring of focused ultrasound/magnetic nanoparticle targeting delivery of therapeutic agents to the brain. Proc Natl Acad Sci 2010, 107:15205-15210.
22. Kim J., Piao Y., Hyeon T. Multifunctional nanostructured materials for multimodal imaging, and simultaneous imaging and therapy. Chem Soc Rev 2009, 38:372-390.
23. Louie A. Multimodality imaging probes: design and challenges. Chem Rev 2010, 110:3146-3195.
24. Yang F., Li Y., Chen Z., Zhang Y., Wu J., Gu N. Superparamagnetic iron oxide nanoparticle-embedded encapsulated microbubbles as dual contrast agents of magnetic resonance and ultrasound imaging. Biomaterials 2009, 30:3882-3890.
25. Schutt E.G., Klein D.H., Mattrey R.M., Riess J.G. Injectable microbubbles as contrast agents for diagnostic ultrasound imaging: the key role of perfluorochemicals. Angew Chem Int Ed 2003, 42:3218-3235.
26. Vlaskou D., Mykhaylyk O., Krötz F., Hellwig N., Renner R., Schillinger U., et al. Magnetic and acoustically active lipospheres for magnetically targeted nucleic acid delivery. Adv Funct Mater 2010, 20:3881-3894.
27. Hu H., Zhou H., Du J., Wang Z., An L., Yang H., et al. Biocompatible hollow silica microspheres as novel ultrasound contrast agents for in vivo imaging. J Mater Chem 2011, 21:6576-6583.
28. Niu D., Wang X., Li Y., Zheng Y., Li F., Chen H., et al. Facile synthesis of magnetite/perfluorocarbon co-loaded organic/inorganic hybrid vesicles for dual-modality ultrasound/magnetic resonance imaging and imaging-guided high-intensity focused ultrasound ablation. Adv Mater 2013, 25:2686-2692.
29. Wang X., Chen H., Chen Y., Ma M., Zhang K., Li F., et al. Perfluorohexane-encapsulated mesoporous silica nanocapsules as enhancement agents for highly efficient high intensity focused ultrasound (HIFU). Adv Mater 2012, 24:785-791.
30. Chen Y., Chen H., Sun Y., Zheng Y., Zeng D., Li F., et al. Multifunctional mesoporous composite nanocapsules for highly efficient MRI-guided high-intensity focused ultrasound cancer surgery. Angew Chem Int Ed 2011, 50:12505-12509.
31. Chen Y., Yin Q., Ji X., Zhang S., Chen H., Zheng Y., et al. Manganese oxide-based multifunctionalized mesoporous silica nanoparticles for pH-responsive MRI, ultrasonography and circumvention of MDR in cancer cells. Biomaterials 2012, 33:7126-7137.
32. Huang X., Teng X., Chen D., Tang F., He J. The effect of the shape of mesoporous silica nanoparticles on cellular uptake and cell function. Biomaterials 2010, 31:438-448.
33. Lin Y.S., Haynes C.L. Impacts of mesoporous silica nanoparticle size, pore ordering, and pore integrity on hemolytic activity. J Am Chem Soc 2010, 132:4834-4842.
34. Bauer A.T., Strozyk E.A., Gorzelanny C., Westerhausen C., Desch A., Schneider M.F., et al. Cytotoxicity of silica nanoparticles through exocytosis of von willebrand factor and necrotic cell death in primary human endothelial cells. Biomaterials 2011, 32:8385-8393.
35. Liu T., Li L., Teng X., Huang X., Liu H., Chen D., et al. Single and repeated dose toxicity of mesoporous hollow silica nanoparticles in intravenously exposed mice. Biomaterials 2011, 32:1657-1668.
36. Chen X., Conti P.S., Moats R.A. In vivo near-infrared fluorescence imaging of integrin αvβ3 in brain tumor xenografts. Cancer Res 2004, 64:8009-8014.
37. Cai W., Chen X. Preparation of peptide-conjugated quantum dots for tumor vasculature-targeted imaging. Nat Protoc 2008, 3:89-96.
38. Zhang L., Xue H., Gao C., Carr L., Wang J., Chu B., et al. Imaging and cell targeting characteristics of magnetic nanoparticles modified by a functionalizable zwitterionic polymer with adhesive 3,4-dihydroxyphenyl-l-alanine linkages. Biomaterials 2010, 31:6582-6588.
39. Palmowski M., Huppert J., Ladewig G., Hauff P., Reinhardt M., Mueller M.M., et al. Molecular profiling of angiogenesis with targeted ultrasound imaging: early assessment of antiangiogenic therapy effects. Mol Cancer Ther 2008, 7:101-109.
40. Qi G., Wang Y., Estevez L., Switzer A.K., Duan X., Yang X., et al. Facile and scalable synthesis of monodispersed spherical capsules with a mesoporous shell. Chem Mater 2010, 22:2693-2695.
41. Deng Z., Chen M., Zhou S., You B., Wu L. A novel method for the fabrication of monodisperse hollow silica spheres. Langmuir 2006, 22:6403-6407.
42. Voisin P., Ribot E.J., Miraux S., Bouzier-Sore A.K., Lahitte J.F., Bouchaud V., et al. Use of lanthanide-grafted inorganic nanoparticles as effective contrast agents for cellular uptake imaging. Bioconjug Chem 2007, 18:1053-1063.
43. 2-weighted magnetic resonance imaging of tumors using multifunctional gadolinium-labeled superparamagnetic iron oxide nanoparticles. Biomaterials 2011, 32:4584-4593.
44. 4 hybrid MRI contrast agents. Biomaterials 2011, 32:4867-4876.
45. Slowing I.I., Wu C.W., Vivero-Escoto J.L., Lin V.S.Y. Mesoporous silica nanoparticles for reducing hemolytic activity towards mammalian red blood cells. Small 2009, 5:57-62.
46. Monsky W.L., Fukumura D., Gohongi T., Ancukiewcz M., Weich H.A., Torchilin V.P., et al. Augmentation of transvascular transport of macromolecules and nanoparticles in tumors using vascular endothelial growth factor. Cancer Res 1999, 59:4129-4135.
47. Oeffinger B.E., Wheatley M.A. Development and characterization of a nano-scale contrast agent. Ultrasonics 2004, 42:343-347.
48. Debouttière P.J., Roux S., Vocanson F., Billotey C., Beuf O., Favre-Réguillon A., et al. Design of gold nanoparticles for magnetic resonance imaging. Adv Funct Mater 2006, 16:2330-2339.
49. Turner J.L., Pan D., Plummer R., Chen Z., Whittaker A.K., Wooley K.L. Synthesis of gadolinium-labeled shell-crosslinked nanoparticles for magnetic resonance imaging applications. Adv Funct Mater 2005, 15:1248-1254.
50. 3+-based MRI contrast agents by conjugation with hydrophobic fluorescent dyes. Bioconjug Chem 2011, 22:2227-2236.
51. 2-weighted magnetic resonance imaging. Bioconjug Chem 2010, 21:505-512.
52. Maeda H. Tumor-selective delivery of macromolecular drugs via the EPR effect: background and future prospects. Bioconjug Chem 2010, 21:797-802.
53. Fang J., Nakamura H., Maeda H. The EPR effect: unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect. Adv Drug Deliv Rev 2011, 63:136-151.
54. Kumar R., Roy I., Ohulchanskky T.Y., Vathy L.A., Bergey E.J., Sajjad M., et al. In vivo biodistribution and clearance studies using multimodal organically modified silica nanoparticles. ACS Nano 2010, 4:699-708.
55. 3 nanorods. Biomaterials 2013, 34:508-515.
56. Hauck T.S., Anderson R.E., Fischer H.C., Newbigging S., Chan W.C.W. In vivo quantum-dot toxicity assessment. Small 2010, 6:138-144.
57. Petterino C., Argentino-Storino A. Clinical chemistry and haematology historical data in control sprague-dawley rats from pre-clinical toxicity studies. Exp Toxicol Pathol 2006, 57:213-219.
58. Dobrovolskaia M.A., Aggarwal P., Hall J.B., McNeil S.E. Preclinical studies to understand nanoparticle interaction with the immune system and its potential effects on nanoparticle biodistribution. Mol Pharm 2008, 5:487-495.